Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.38 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | CLK2 | P49760 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14940558 | 0.90 | CYP3A4 (0.38) | ALDH1A1KDM4EHPGDGSK3BCYP1A2 | |
| SCHEMBL4723533 | 0.86 | CYP1A2 (0.53) | ALDH1A1KDM4EHPGDCYP1A2MEN1 | |
| SCHEMBL7017055 | 0.84 | KDM4E (0.44) | ALDH1A1KDM4EHPGDCSNK2A2CSNK2B | |
| SCHEMBL7512756 | 0.84 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDGSK3BCSNK2A2 | |
| SCHEMBL4721467 | 0.83 | KDM4E (0.43) | ALDH1A1KDM4EHPGDCSNK2A2CSNK2B | |
| SCHEMBL8117111 | 0.80 | ALDH1A1 (0.48) | ALDH1A1KDM4EHPGDGSK3BCSNK2A2 | |
| SCHEMBL9535556 | 0.80 | ALDH1A1 (0.48) | ALDH1A1KDM4EHPGDGSK3BCSNK2A2 | |
| SCHEMBL7517309 | 0.76 | KDM4E (0.35) | ALDH1A1KDM4EHPGDCSNK2A2CSNK2B | |
| SCHEMBL1629770 | 0.76 | KDM4E (0.37) | ALDH1A1KDM4EHPGDCSNK2A2CSNK2B | |
| SCHEMBL1552485 | 0.76 | ALDH1A1 (0.37) | ALDH1A1KDM4EHPGDCSNK2A2CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303271-A1 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION | Taigen Biotechnology Co., Ltd. (TW) | 2011-04-06 | — | — | EP | disclosed |
| EP-2185143-A2 | ANTIMICROBIAL PARENTERAL FORMULATION | Taigen Biotechnology Co., Ltd. (TW) | 2010-05-19 | — | — | EP | disclosed |
| WO-2010009014-A2 | ANTIBIOTIC DRUG | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010002415-A1 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| WO-2010002965-A2 | PNEUMONIA TREATMENT | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009023473-A2 | ANTIMICROBIAL PARENTERAL FORMULATION | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2009-02-19 | — | — | WO | disclosed |
| EP-2001862-A2 | MALATE SALTS, AND POLYMORPHS OF (3S,5S)-7-Ý3-AMINO-5-METHYL-PIPERIDINYL¨-1-CYCLOPROPYL-1,4-DIHYDRO-8-METHOXY-4-OXO-3-QUINOLINECARBOXYLIC ACID | The Procter and Gamble Company (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1999125-A2 | A COUPLING PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | The Procter and Gamble Company (US) | 2008-12-10 | — | — | EP | disclosed |
| EP-1999106-A1 | A HYDRIDE REDUCTION PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | The Procter and Gamble Company (US) | 2008-12-10 | — | — | EP | disclosed |
| EP-1931684-A2 | OXAZOLIDINONE-QUINOLONE HYBRIDS AS ANTIBACTERIAL COMPOUNDS | Actelion Pharmaceuticals Ltd. (CH) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007110836-A1 | A HYDRIDE REDUCTION PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007110834-A2 | MALATE SALTS, AND POLYMORPHS OF (3S,5S)-7-[3-AMINO-5-METHYL-PIPERIDINYL]-1-CYCLOPROPYL-1,4-DIHYDRO-8-METHOXY-4-OXO-3-QUINOLINECARBOXYLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007110835-A2 | A COUPLING PROCESS FOR PREPARING QUINOLONE INTERMEDIATES | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007017828-A2 | OXAZOLIDINONE-QUINOLONE HYBRIDS AS ANTIBACTERIAL COMPOUNDS | ACTELION PHARMACEUTICALS LTD (CH) | 2007-02-15 | — | — | WO | disclosed |
| EP-1432705-A2 | DUAL ACTION ANTIBIOTICS | Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003032962-A2 | DUAL ACTION ANTIBIOTICS | Morphochem Aktiengesellschaft für kombinatorische Chemie (DE) | 2003-04-24 | — | — | WO | disclosed |
| EP-1015445-A1 | ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999014214-A1 | ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |